
What We're Reading: Opioid Prescription Disparities; Trump Backs Drug Import Plan; High Cost of Drugs Approved in 2018
White patients are significantly more likely to be prescribed buprenorphine compared with patients of other races/ethnicities; Trump has backed a Florida proposal to import drugs from Canada; nearly 25% of medications approved in 2018 cost more than $30,000 per year.
White Patients More Likely to Be Prescribed Opioids
Trump Backs Plan to Import Drugs From Canada
Between 2012 and 2015, white populations were almost 35 times more likely to be prescribed buprenorphine than patients of other races/ethnicities (12.7 million vs 363,000), according to a study published in
1 in 4 Prescriptions Approved in 2018 Cost Over $30,000
Out of approximately 100 medications approved in 2018, 23 of them came with a list price of more than $30,000 per year for a course of treatment, according to an
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.